Dexamethasone Sodium Phosphate
- Product NDC
- 84549-422
- 11-digit product format
- 845490422
- Labeler code
- 84549
- Product ID
- 84549-422_463e9fbd-e8ee-a852-e063-6394a90aa848
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Dexamethasone Sodium Phosphate
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS; SOFT TISSUE
- Labeler
- ProPharma Distribution
- Application
- ANDA040803
- Marketing category
- ANDA
- Marketing start
- 2011-05-11
- Substance
- DEXAMETHASONE SODIUM PHOSPHATE
- Active strength
- 4 mg/mL
- Pharmacologic classes
- Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A040803-001 | DEXAMETHASONE SODIUM PHOSPHATE | DEXAMETHASONE SODIUM PHOSPHATE | EQ 4MG PHOSPHATE/ML | INJECTABLE / INJECTION | AP | 2008-08-29 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A040803-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A040803-001 | DEXAMETHASONE SODIUM PHOSPHATE | EQ 4MG PHOSPHATE/ML | INJECTABLE / INJECTION | AP | 2008-08-29 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A040803-001 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Sportpharm LLC | a8aee11f-c928-41ef-8df8-e6d8b355536c | 2026-07-10 | Warnings, Adverse reactions | 040803 ANDA040803 |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Henry Schein, Inc. | c464ffde-f64e-4716-92d2-720a10793248 | 2026-01-02 | Warnings, Adverse reactions | 040803 ANDA040803 |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | ProPharma Distribution | 384206f5-75ed-9bd2-e063-6294a90a5038 | 2025-12-18 | Warnings, Adverse reactions | 040803 ANDA040803 |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | ProPharma Distribution | 42c879cc-38dc-c9bc-e063-6294a90a204d | 2025-12-18 | Warnings, Adverse reactions | 040803 ANDA040803 84549-422 |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Asclemed USA, Inc. | 36854dbc-22f2-5df9-e063-6394a90ad934 | 2025-06-06 | Warnings, Adverse reactions | 040803 ANDA040803 |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | A-S Medication Solutions | d21f3055-8a8a-4797-93e2-c8f582cbdae1 | 2024-04-11 | Warnings, Adverse reactions | 040803 ANDA040803 |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Mylan Institutional LLC | dff598e8-e662-411f-978d-4ba3fb8ef7db | 2024-03-05 | Warnings, Adverse reactions | 040803 ANDA040803 |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Medical Purchasing Solutions, LLC | 86091483-2053-5da8-e053-2a91aa0a6f45 | 2023-05-16 | Warnings, Adverse reactions | 040803 ANDA040803 |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Medical Purchasing Solutions, LLC | 81a28bdb-b186-8047-e053-2a91aa0a4e0a | 2023-05-16 | Warnings, Adverse reactions | 040803 ANDA040803 |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Medical Purchasing Solutions, LLC | 81a0503c-39fe-1c67-e053-2a91aa0a5b8f | 2023-05-16 | Warnings, Adverse reactions | 040803 ANDA040803 |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Asclemed USA, Inc. | b2ce414a-3b1f-4533-bb3a-18594529dead | 2020-11-25 | Warnings, Adverse reactions | 040803 ANDA040803 |
| Dexamethasone Sodium Phosphate | DEXAMETHASONE SODIUM PHOSPHATE | Mylan Institutional LLC | 836f8017-d023-410b-8515-ec776e73ca59 | 2019-11-04 | Warnings, Adverse reactions | 040803 ANDA040803 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Dexamethasone Sodium Phosphate
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DEXAMETHASONE SODIUM PHOSPHATE | 4 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| AI9376Y64P | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1116927 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 42c879cc-38dc-c9bc-e063-6294a90a204d | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 1ea46721-9071-6b81-fd0a-a82bfbb014ec | Product name | 7 | 20250220 |
| 525701df-f985-480d-995a-e0ee70c2bdf4 | Product name | 5 | 20250128 |
| ea50b939-d92a-4100-84f5-1c1089663837 | Product name | 2 | 20240705 |
| 941f67d9-7f03-56d2-750c-36de24f654db | Product name | 3 | 20221117 |
| d7d46a10-8766-d3c8-ebf2-2ccd9efdcae8 | Product name | 2 | 20220506 |
| 7b2c58e8-5850-4e3e-82e9-b1593b1de761 | Product name | 5 | 20220210 |
| 81e34474-b0a5-434f-8104-25d689efc99e | Product name | 1 | 20200303 |
| 05ab9c01-cd9a-4f59-b2e8-ddcb887cac39 | Product name | 1 | 20190408 |
| 0c7dba41-c919-5809-508d-4affe6cfcff2 | Product name | 2 | 20170817 |
| 399647c0-db89-02d1-991c-0c17b584482c | Product name | 1 | 20140508 |
| 3e9a6377-704f-dff7-b19f-56c98d40c444 | Product name | 1 | 20140508 |
| 4d2e6ff9-14f5-b84f-c39b-373b005712c1 | Product name | 1 | 20140508 |
| 725d71bf-f956-5cad-e556-fa39cb060dc8 | Product name | 1 | 20140508 |
| 9ea85abb-fa68-5da6-ab60-2c7eef579000 | Product name | 1 | 20140508 |
| d029211e-5e6b-725f-3696-ac6ff77da222 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 84549-422-54 | Dexamethasone Sodium Phosphate | 5 mL in 1 VIAL | INJECTION, SOLUTION | 5 | 2 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1116927 | dexAMETHasone sodium phosphate 4 MG/ML (dexAMETHasone phosphate equivalent) Injectable Solution | PSN | 42c879cc-38dc-c9bc-e063-6294a90a204d | 2 |
| 1116927 | dexamethasone phosphate 4 MG/ML Injectable Solution | SCD | 42c879cc-38dc-c9bc-e063-6294a90a204d | 2 |
| 1116927 | dexamethasone phosphate 4 MG/ML (as dexamethasone sodium phosphate 4.4 MG/ML) Injectable Solution | SY | 42c879cc-38dc-c9bc-e063-6294a90a204d | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 84549-422-54 | 84549042254 | 5 mL in 1 VIAL (84549-422-54) | 5 ml | 2025-11-04 | No | No | Current |